Lhasa Limited shared knowledge shared progress
Loading...
PublicationsJump to results
Authors
Publication Type
Publication Year
Related Products
Reset
New search
TitlePublishedTypeProducts
A Suggested ICH M7 Framework Using Lhasa Limited ProductsMay 2019pdf fileZenethVitic NexusMirabilisSarah NexusDerek Nexus
A Case Study in Predicting hERG Activity.April 2019Derek NexusSarah NexusMirabilisMeteor NexusKaptisEffirisVitic NexusZenethSetaria
Improving In Silico Predictions in Developmental and Reproductive ToxicologyApril 2019Derek NexusSarah Nexus
ICH M7 Perception: Unifying Knowledge from Predictions to PurgingMarch 2019pdf fileMirabilisSetariaDerek NexusSarah NexusVitic Nexus
Product Update ICGM PresentationMarch 2019pdf fileDerek NexusSarah Nexus
Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case study in an industrial settingFebruary 2019Sarah NexusDerek Nexus
Advance your knowledge of ICH M7 A virtual expert review workshopFebruary 2019Derek NexusSarah Nexus
Save Time and Money with Lhasa LimitedDecember 2018pdf fileDerek NexusSarah NexusZeneth
Welcome and Introduction to ICH M7 - ICH M7 India RoadshowsNovember 2018pdf fileDerek NexusSarah NexusVitic Nexus
Sarah Nexus: The Statistical System for ICH M7 - ICH M7 India RoadshowsNovember 2018pdf fileSarah Nexus
Derek Nexus, Sarah Nexus and Vitic: How they fit into ICH M7 - ICH M7 India RoadshowsNovember 2018pdf fileDerek NexusSarah NexusVitic Nexus
An adverse outcome pathway framework to support developmental and reproductive toxicity risk assessmentsNovember 2018pdf fileDerek NexusSarah NexusVitic Nexus
Important considerations for the validation of QSAR models for in vitro mutagenicityNovember 2018Derek NexusSarah NexusVitic Nexus
Improvement of quantitative structure–activity relationship (QSAR) tools for predicting Ames mutagenicity: outcomes of the Ames/QSAR International Challenge ProjectOctober 2018Derek NexusSarah Nexus
In Silico Predictions For GenotoxicityOctober 2018pdf fileDerek NexusSarah Nexus
Interpreting the Sensitivity and Equivocal Settings in Sarah NexusOctober 2018pdf fileSarah Nexus
Meeting report, ICH M7 relevant workshop: use of (Q)SAR systems and expert judgmentSeptember 2018pdf fileDerek NexusSarah Nexus
Development Of A Network Of Adverse Outcome Pathways (AOPs) For CarcinogenicitySeptember 2018pdf fileVitic NexusDerek NexusSarah Nexus
Mutagenicity Predictions using a Statistical SystemJune 2018pdf fileSarah Nexus
Toxicity Studies for Degradation Impurities - An Industry PerspectiveJune 2018pdf fileDerek NexusSarah Nexus
ICH M7 Use CasesJune 2018pdf fileDerek NexusSarah Nexus
Strain Profiles: Moving Beyond Binary Ames Classification - A SummaryApril 2018Sarah Nexus
Sarah Nexus Strain InformationMarch 2018pdf fileSarah Nexus
49th ICGM Product Manager UpdateMarch 2018pdf fileDerek NexusMeteor NexusMirabilisSarah NexusSetariaVitic NexusZeneth
Using New Features to Further Interrogate Sarah Nexus PredictionsMarch 2018pdf fileSarah Nexus

© 2019 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.